| Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report RK Gupta, D Peppa, AL Hill, C Gálvez, M Salgado, M Pace, LE McCoy, ... The Lancet HIV 7 (5), e340-e347, 2020 | 226 | 2020 |
| Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV A Alrubayyi, E Gea-Mallorquí, E Touizer, D Hameiri-Bowen, J Kopycinski, ... Nature Communications 12 (1), 5839, 2021 | 101 | 2021 |
| Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV E Touizer, A Alrubayyi, C Rees-Spear, N Fisher-Pearson, SA Griffith, ... The lancet. HIV 8 (6), e317, 2021 | 42 | 2021 |
| Differential inhibitory receptor expression on T cells delineates functional capacities in chronic viral infection JE Teigler, G Zelinskyy, MA Eller, DL Bolton, M Marovich, AD Gordon, ... Journal of virology 91 (23), 10.1128/jvi. 01263-17, 2017 | 41 | 2017 |
| A flow cytometry based assay that simultaneously measures cytotoxicity and monocyte mediated antibody dependent effector activity A Alrubayyi, A Schuetz, KG Lal, S Jongrakthaitae, KM Paolino, JA Ake, ... Journal of Immunological Methods 462, 74-82, 2018 | 23 | 2018 |
| Innate immunology in COVID-19—a living review. Part II: dysregulated inflammation drives immunopathology PRS Rodrigues, A Alrubayyi, E Pring, VMT Bart, R Jones, C Coveney, ... Oxford open immunology 1 (1), iqaa005, 2020 | 22 | 2020 |
| SARS-CoV-2 immunity and vaccine strategies in people with HIV C Mullender, KAS da Costa, A Alrubayyi, SL Pett, D Peppa Oxford Open Immunology 3 (1), iqac005, 2022 | 16 | 2022 |
| Associations between antibody Fc-mediated effector functions and long-term sequelae in Ebola virus survivors D Paquin-Proulx, BM Gunn, A Alrubayyi, DV Clark, M Creegan, D Kim, ... Frontiers in Immunology 12, 682120, 2021 | 16 | 2021 |
| RV144 HIV-1 vaccination impacts post-infection antibody responses T Mdluli, N Jian, B Slike, D Paquin-Proulx, G Donofrio, A Alrubayyi, S Gift, ... PLoS Pathogens 16 (12), e1009101, 2020 | 16 | 2020 |
| Harnessing natural killer cell innate and adaptive traits in HIV infection A Alrubayyi, A Ogbe, E Moreno Cubero, D Peppa Frontiers in cellular and infection microbiology 10, 395, 2020 | 15 | 2020 |
| NK cells in COVID-19: protectors or opponents? A Alrubayyi Nature Reviews Immunology 20 (9), 520-520, 2020 | 14 | 2020 |
| Innate immunology in COVID-19—a living review. Part I: viral entry, sensing and evasion C Coveney, M Tellier, F Lu, S Maleki-Toyserkani, R Jones, VMT Bart, ... Oxford Open Immunology 1 (1), iqaa004, 2020 | 14 | 2020 |
| Attenuated humoral responses in HIV after SARS-CoV-2 vaccination linked to B cell defects and altered immune profiles E Touizer, A Alrubayyi, R Ford, N Hussain, PP Gerber, HL Shum, ... Iscience 26 (1), 2023 | 12 | 2023 |
| Functional restoration of exhausted CD8 T cells in chronic HIV-1 infection by targeting mitochondrial dysfunction A Alrubayyi, E Moreno-Cubero, D Hameiri-Bowen, R Matthews, ... Frontiers in immunology 13, 908697, 2022 | 10 | 2022 |
| Characterization of SARS-CoV-2–specific responses in people living with HIV AS Alrubayyi, E Gea-Mallorqui, E Touizer, D HameiriBowen, D Kopycinski, ... Virtual Conference on Retroviruses and Opportunistic Infections. San …, 2021 | 9 | 2021 |
| Impact of obesity and SARS-CoV-2 infection: implications for host defence-a living review FC Richter, A Alrubayyi, A Teijeira Crespo, ... Oxford Open Immunology 2 (1), iqab001, 2021 | 9 | 2021 |
| Natural killer cells during acute HIV-1 infection: clues for HIV-1 prevention and therapy A Alrubayyi, S Rowland-Jones, D Peppa AIDS 36 (14), 1903-1915, 2022 | 6 | 2022 |
| Seeing SARS-CoV-2 variants through the eyes of T cells A Alrubayyi, D Peppa Nature Reviews Immunology 21 (5), 274-274, 2021 | 5 | 2021 |
| Evidence for HIV-1 cure after CCR5D32/D32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report. Lancet HIV 7: e340–e347 RK Gupta, D Peppa, AL Hill, C Gálvez, M Salgado, M Pace, LE McCoy, ... | 5 | 2020 |
| Humoral and cellular responses to SARS‐CoV‐2 in patients with B‐cell haematological malignancies improve with successive vaccination CL Pinder, D Jankovic, TA Fox, A Kirkwood, L Enfield, A Alrubayyi, ... British Journal of Haematology 202 (6), 1091-1103, 2023 | 4 | 2023 |
